LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | BI-2536 | 0.12 | uM | LJP6 | 72 | hr | 1334 | 574 | 3970 | 0.1447 | -0.2883 |
BT-20 | BMS345541 | 0.12 | uM | LJP6 | 72 | hr | 1334 | 3799 | 3970 | 0.9569 | 0.9350 |
BT-20 | SNS-032 | 0.12 | uM | LJP6 | 72 | hr | 1334 | 2372 | 3970 | 0.5975 | 0.3937 |
BT-20 | GDC-0980 | 0.12 | uM | LJP5 | 72 | hr | 1334 | 1553 | 3970 | 0.3913 | 0.0831 |
BT-20 | NVP-AEW541 | 0.12 | uM | LJP5 | 72 | hr | 1334 | 4059 | 3970 | 1.0222 | 1.0334 |
BT-20 | SB590885 | 0.12 | uM | LJP5 | 72 | hr | 1334 | 4065 | 3970 | 1.0239 | 1.0359 |
BT-20 | PIK-93 | 0.12 | uM | LJP5 | 72 | hr | 1334 | 4135 | 3970 | 1.0414 | 1.0624 |
BT-20 | KIN001-043 | 0.12 | uM | LJP6 | 72 | hr | 1334 | 3691 | 3970 | 0.9295 | 0.8938 |
BT-20 | Alpelisib | 0.12 | uM | LJP5 | 72 | hr | 1334 | 4100 | 3970 | 1.0326 | 1.0491 |
BT-20 | Luminespib | 0.12 | uM | LJP5 | 72 | hr | 1334 | 945 | 3970 | 0.2380 | -0.1478 |
BT-20 | A443654 | 0.12 | uM | LJP6 | 72 | hr | 1334 | 2994 | 3970 | 0.7540 | 0.6294 |
BT-20 | OSI-027 | 0.12 | uM | LJP6 | 72 | hr | 1334 | 3659 | 3970 | 0.9216 | 0.8819 |
BT-20 | XMD11-85h | 0.12 | uM | LJP6 | 72 | hr | 1334 | 4089 | 3970 | 1.0299 | 1.0450 |
BT-20 | HG-6-64-01 | 0.12 | uM | LJP6 | 72 | hr | 1334 | 4124 | 3970 | 1.0386 | 1.0582 |
BT-20 | WH-4-025 | 0.12 | uM | LJP5 | 72 | hr | 1334 | 3131 | 3970 | 0.7887 | 0.6817 |
BT-20 | WZ-4-145 | 0.12 | uM | LJP6 | 72 | hr | 1334 | 3753 | 3970 | 0.9453 | 0.9176 |
BT-20 | XMD16-144 | 0.12 | uM | LJP5 | 72 | hr | 1334 | 2327 | 3970 | 0.5861 | 0.3765 |
BT-20 | Brivanib | 0.12 | uM | LJP5 | 72 | hr | 1334 | 3864 | 3970 | 0.9732 | 0.9596 |
BT-20 | Buparlisib | 0.12 | uM | LJP5 | 72 | hr | 1334 | 3831 | 3970 | 0.9649 | 0.9471 |
BT-20 | BX-912 | 0.12 | uM | LJP5 | 72 | hr | 1334 | 3931 | 3970 | 0.9901 | 0.9851 |
BT-20 | Canertinib | 0.12 | uM | LJP6 | 72 | hr | 1334 | 3574 | 3970 | 0.9001 | 0.8494 |
BT-20 | Celastrol | 0.12 | uM | LJP6 | 72 | hr | 1334 | 4099 | 3970 | 1.0323 | 1.0487 |
BT-20 | CGP60474 | 0.12 | uM | LJP5 | 72 | hr | 1334 | 843 | 3970 | 0.2123 | -0.1865 |
BT-20 | CGP60474 | 0.12 | uM | LJP6 | 72 | hr | 1334 | 531 | 3970 | 0.1337 | -0.3049 |
BT-20 | CHIR-99021 | 0.12 | uM | LJP6 | 72 | hr | 1334 | 3649 | 3970 | 0.9189 | 0.8779 |